Sale of Securities

MoonLake Immunotherapeutics Filed 2025-12-08 Acc 0001969223-25-001045

Documents 1

2026-03-31 144 Sale of Securities
2025-12-10 4 Chief Executive Officer sold 200,000 shares at an average $14.87 ($2,974,700)
2025-12-10 4 Chief Scientific Officer sold 202,908 shares at an average $14.85 ($3,012,462)
2025-12-08 144 Sale of Securities
2025-12-08 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…